-
1
-
-
0035032426
-
Andropause: Is it time for the geriatrician to treat it?
-
Morley JE. Andropause: Is it time for the geriatrician to treat it? (Editorial). J Gerontol Med Sci. 2001:56A:M263-M265.
-
(2001)
J Gerontol Med Sci
, vol.56 A
-
-
Morley, J.E.1
-
2
-
-
0033962431
-
Andropause: A misnomer for a true clinical entity
-
Morales A, Heaton JPW, Carson CC. Andropause: A misnomer for a true clinical entity. J Urol. 2000;163:705-712.
-
(2000)
J Urol
, vol.163
, pp. 705-712
-
-
Morales, A.1
Heaton, J.P.W.2
Carson, C.C.3
-
3
-
-
0031646985
-
Male hormone replacement therapy including "andropause"
-
Tenover JL. Male hormone replacement therapy including "andropause." Endocrinol Metab Clin North Am. 1998;27:969-987.
-
(1998)
Endocrinol Metab Clin North Am
, vol.27
, pp. 969-987
-
-
Tenover, J.L.1
-
4
-
-
0033125818
-
Current status of testosterone replacement therapy in men
-
Winters SJ. Current status of testosterone replacement therapy in men. Arch Fam Med. 1999;8:257-263.
-
(1999)
Arch Fam Med
, vol.8
, pp. 257-263
-
-
Winters, S.J.1
-
5
-
-
0034712454
-
For and against: The male menopause - Does it exist?
-
Gould DC, Petty R, Jacobs HS. For and against: The male menopause - Does it exist? Br Med J. 2000;320:858-861.
-
(2000)
Br Med J
, vol.320
, pp. 858-861
-
-
Gould, D.C.1
Petty, R.2
Jacobs, H.S.3
-
6
-
-
0036176556
-
Andropause: Clinical implications of the decline in serum testosterone levels with aging in men
-
Matsumoto AM. Andropause: Clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol Med Sci. 2002;57A:M76-M99.
-
(2002)
J Gerontol Med Sci
, vol.57 A
-
-
Matsumoto, A.M.1
-
8
-
-
0031001347
-
Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men
-
Morley JE, Kaiser FE, Perry HM, et al. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism. 1997;46:410-413.
-
(1997)
Metabolism
, vol.46
, pp. 410-413
-
-
Morley, J.E.1
Kaiser, F.E.2
Perry, H.M.3
-
9
-
-
0035344088
-
Hypogonadism and androgen replacement therapy in elderly men
-
Basaria S, Dobs AS. Hypogonadism and androgen replacement therapy in elderly men. Am J Med. 2001;110:563-572.
-
(2001)
Am J Med
, vol.110
, pp. 563-572
-
-
Basaria, S.1
Dobs, A.S.2
-
10
-
-
0033821819
-
Validation of a screening questionnaire for androgen deficiency in aging males
-
Morley JE, Charlton E, Patrick P, et al, Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism. 2000; 49:1239-1242.
-
(2000)
Metabolism
, vol.49
, pp. 1239-1242
-
-
Morley, J.E.1
Charlton, E.2
Patrick, P.3
-
11
-
-
0034492440
-
Construction and field validation of a self-administered screener for testosterone deficiency (hypogonadism) in ageing men
-
Smith KW, Feldman HA, McKinlay JB. Construction and field validation of a self-administered screener for testosterone deficiency (hypogonadism) in ageing men. Clin Endocrinol (Oxf). 2000;53:703-711.
-
(2000)
Clin Endocrinol (Oxf)
, vol.53
, pp. 703-711
-
-
Smith, K.W.1
Feldman, H.A.2
McKinlay, J.B.3
-
12
-
-
0012104429
-
AHFS Drug Information [Book on online database]
-
Jackson, WY: Teton Data Systems. Bethesda, MD: American Society of Health System Pharmacists; 2002. STAT!-Ref Medical Reference Library
-
AHFS Drug Information, [Book on online database]. Jackson, WY: Teton Data Systems; 2002. Based on: AHFS Drug Information, forty fourth edition. Bethesda, MD: American Society of Health System Pharmacists; 2002. STAT!-Ref Medical Reference Library.
-
(2002)
AHFS Drug Information, Forty Fourth Edition
-
-
-
15
-
-
0032870080
-
Risks versus benefits of testosterone therapy in elderly men
-
Basaria S, Dobs AS. Risks versus benefits of testosterone therapy in elderly men. Drugs Aging. 1999;15:131-142.
-
(1999)
Drugs Aging
, vol.15
, pp. 131-142
-
-
Basaria, S.1
Dobs, A.S.2
-
16
-
-
0034456450
-
Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men
-
Wang C, Swerdloff RS, Iranmanesh A, et al. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab. 2000;85:2839-2853.
-
(2000)
J Clin Endocrinol Metab
, vol.85
, pp. 2839-2853
-
-
Wang, C.1
Swerdloff, R.S.2
Iranmanesh, A.3
-
17
-
-
0035028887
-
Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels
-
Kenny AM, Prestwood KM, Gruman CA, Marcello KM, Raisz LG. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels. J Gerontol Med Sci. 2001; 56A:M266-M272.
-
(2001)
J Gerontol Med Sci
, vol.56 A
-
-
Kenny, A.M.1
Prestwood, K.M.2
Gruman, C.A.3
Marcello, K.M.4
Raisz, L.G.5
-
19
-
-
0006524604
-
AACE clinical practice guidelines for the evaluation and treatment of hypogonadism in adult male patients
-
American Association of Clinical Endocrinologists, American College of Endocrinology. AACE clinical practice guidelines for the evaluation and treatment of hypogonadism in adult male patients. Endocr Prac. 1996;Nov/Dec:439-453.
-
(1996)
Endocr Prac
, vol.NOV-DEC
, pp. 439-453
-
-
-
20
-
-
0012048204
-
-
Scott-Levin Source Prescription Audit, Quintiles Transnational Corp. Research Triangle Park, NC
-
Scott-Levin Source Prescription Audit, Quintiles Transnational Corp. Research Triangle Park, NC.
-
-
-
|